Accelerated proteasomal activity induced by Pb2+, Ga 3+, or Cu2+ exposure does not induce degradation of αt-Synuclein

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 28, Issue 1, 2009, Pages 5-24

  Grunberg Etkovitz, Nurit ^a   Lev, Nirit ^b   Ickowicz, Debby ^b   Avital, Almog ^a   Offen, Daniel ^b   Malik, Zvi ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

A53T mutant; Heavy metals; Heme oxygenase 1

Indexed keywords

ALPHA SYNUCLEIN; CUPRIC CHLORIDE; CYCLIN DEPENDENT KINASE 1; GALLIUM NITRATE; HEAVY METAL; HEME OXYGENASE 1; HEMIN; LEAD ACETATE; PORPHOBILINOGEN SYNTHASE; PROTEASOME; PROTEIN INHIBITOR; REACTIVE OXYGEN METABOLITE;

AGGRESOME; ARTICLE; CELL DEATH; CELL STRAIN; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME SUBUNIT; HUMAN; HUMAN CELL; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION;

EID: 67549098435     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v28.i1.20     Document Type: Article

References (37)

1. Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol. 996;55:259-72.
2. Lewy FH. Handbuch der Neurologie. In: Lewandowski M, editor. Berlin: Springer; 1912.
3. Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, Hendil KB, Jensen PH. Proteasomal inhibition by alpha-synuclein fi laments and oligomers. J Biol Chem. 2004;279:12924-34.
4. Spillantini MG, Divane A, Goedert M. Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35. Genomics. 1995;27:379-81.
5. Good PF, Hsu A, Werner P, Perl DP, Olanow CW. Protein nitration in Parkinson's isease. J Neuropathol Exp Neurol. 1998;57:338-42.
6. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000; 290:985-9.
7. Tanner CM. The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci. 1989;12:49-54.
8. Rybicki BA, Johnson CC, Uman J, Gorell JM. Parkinson's disease mortality and the industrial use of heavy metals in Michigan. Mov Disord. 1993;8:87-92.
9. Zayed J, Ducic S, Campanella G, Panisset JC, Andre P, Masson H, Roy M. Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci. 1990;17:286-91 (in French).
10. Yasui M, Kihira T, Ota K. Calcium, magnesium and aluminum concentrations in Parkinson's disease. Neurotoxicology. 1992;13:593-600.
11. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology. 1999;20: 239-47.
12. Uversky VN, Li J, Fink AL. Metal-triggered structural transformations, aggregation, and fi brillation of human alpha-synuclein. A possible molecular NK between arkinson's disease and heavy metal exposure. J Biol Chem. 2001;276:44284-96.
13. Lev N, Melamed E, Offen D. Proteasomal inhibition hypersensitizes differentiated euroblastoma cells to oxidative damage. Neurosci Lett. 2006;399:27-32.
14. McNaught KS, Mytilineou C, Jnobaptiste R, Yabut J, Shashidharan P, Jennert P, Olanow CW. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J Neurochem. 2002;81:301-6.
15. Elkon H, Melamed E, Offen D. Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease. J Mol Neurosci. 2004;24:387-400.
16. Bennett MC, Bishop JF, Leng Y, Chock PB, Chase TN, Mouradian MM. Degradation of alpha-synuclein by proteasome. J Biol Chem. 1999;274:33855-8.
17. Lee M, Hyun D, Halliwell B, Jenner P. Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J Neurochem. 2001;76:998-1009.
18. Li N, Venkatesan MI, Miguel A, Kaplan R, Gujuluva C, Alam J, Nel A. Induction of heme oxygenase-1 expression in macrophages by diesel exhaust particle chemicals and quinones via the antioxidant-responsive element. J Immunol. 2000;165:3393-401.
19. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86:583-650.
20. Taketani S, Kohno H, Kinoshita S, Tokunaga R. The effects of lead on differentiation of the Friend leukemia cells and rat bone marrow cells. Toxicol Appl Pharmacol. 1985;77:374-80.
21. Guo GG, Gu M, Etlinger JD. 240-kDa proteasome inhibitor (CF-2) is identical to deltaaminolevulinic acid dehydratase. J Biol Chem. 1994;269:12399-402.
22. Grunberg-Etkovitz N, Greenbaum L, Grinblat B, Malik Z. Proteasomal degradation regulates expression of porphobilinogen deaminase (PBGD) mutants of acute intermittent porphyria. Biochim Biophys Acta. 2006;1762:819-27.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
24. Mauzerall D, Granick S. The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. J Biol Chem. 1956; 219:435-46.
25. Schmidt U, Fuessel S, Koch R, Baretton GB, Lohse A, Tomasetti S, Unversucht S, Froehner M, Wirth MP, Meye A. Quantitative multi-gene expression profi ling of primary prostate cancer. Prostate. 2006;66:1521-34.
26. Tanabe T, Shin M, Fujiwara K. Immunoelectron Begell House Digital Library, http://dl.begellhouse.com Downloaded 2009-5-11 from IP 203.56.241.128 by Elsevier Bibliographic Databases a-SYNUCLEIN STABILITY TO PROTEASOME DEGRADATION JEPTO2009, Volume 28, Number 1 23microscopy study of polyamines using a newly prepared monoclonal antibody against spermidine: use of a mixture of glutaraldehyde and paraformaldehyde as a cross-linking agent in the preparation of the antigen. J Biochem. 2004;135:501-7.
27. Calabrese V, Stella AM, Butterfield DA, Scapagnini G. Redox regulation in eurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance. Antioxid Redox Signal. 2004;6:895-913.
28. Goering PL, Fowler BA. Metal constitution of metallothionein influences inhibition of delta-aminolaevulinic acid dehydratase (porphobilinogen synthase) by lead. Biochem J. 1987;245:339-45.
29. Fujita H, Ishida N, Akagi R. delta-Aminolevulinate dehydratase defi ciency. Nippon Rinsho. 1995;53:1408-17 (in Japanese).
30. Xiao D, Johnson CS, Trump DL, Singh SV. Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells. Mol Cancer Ther. 2004;3:567-75.
31. Tanner CM. Is the cause of Parkinson's disease environmental or hereditary? vidence from twin studies. Adv Neurol. 2003;91:133-42.
32. Gorell JM, Peterson EL, Rybicki BA, Johnson CC. Multiple risk factors for arkinson's disease. J Neurol Sci. 2004;217:169-74.
33. McNaught KS, Olanow CW. Proteolytic stress: a unifying concept for the tiopathogenesis of Parkinson's disease. Ann Neurol. 2003;53 Suppl 3:S73-84, discussion S84-6.
34. Hattori N, Mizuno Y. Pathogenetic mechanisms of parkin in Parkinson's disease. Lancet. 2004;364:722-4.
35. Petrucelli L, Dawson TM. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system. Ann Med. 2004;36:315-20.
36. Haas AL, Rose IA. Hemin inhibits ATPdependent ubiquitin-dependent proteolysis: role of hemin in regulating ubiquitin conjugate degradation. Proc Natl Acad Sci U S A. 1981; 78:6845-8.
37. Gross M, Hessefort S, Olin A. Purifi cation of a 38-kDa protein from rabbit reticulocyte lysate which promotes protein renaturation by heat shock protein 70 and its identifi cation as deltaaminolevulinic acid dehydratase and as a putative DnaJ protein. J Biol Chem. 1999;274:3125-34.